These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1171 related items for PubMed ID: 21992536

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Presence or absence of a positive pathological margin outperforms any other margin-associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer.
    Huang JG, Pedersen J, Hong MK, Harewood LM, Peters J, Costello AJ, Hovens CM, Corcoran NM.
    BJU Int; 2013 May; 111(6):921-7. PubMed ID: 23350712
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?
    Pfitzenmaier J, Pahernik S, Tremmel T, Haferkamp A, Buse S, Hohenfellner M.
    BJU Int; 2008 Nov; 102(10):1413-8. PubMed ID: 18537951
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence.
    Shikanov S, Song J, Royce C, Al-Ahmadie H, Zorn K, Steinberg G, Zagaja G, Shalhav A, Eggener S.
    J Urol; 2009 Jul; 182(1):139-44. PubMed ID: 19450829
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Positive surgical margins are a risk factor for significant biochemical recurrence only in intermediate-risk disease.
    Corcoran NM, Hovens CM, Metcalfe C, Hong MK, Pedersen J, Casey RG, Peters J, Harewood L, Goldenberg SL, Costello AJ, Gleave ME.
    BJU Int; 2012 Sep; 110(6):821-7. PubMed ID: 22257140
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence.
    O'Neil LM, Walsh S, Cohen RJ, Lee S.
    BJU Int; 2015 Oct; 116 Suppl 3():42-8. PubMed ID: 26218868
    [Abstract] [Full Text] [Related]

  • 14. A close surgical margin after radical prostatectomy is an independent predictor of recurrence.
    Lu J, Wirth GJ, Wu S, Chen J, Dahl DM, Olumi AF, Young RH, McDougal WS, Wu CL.
    J Urol; 2012 Jul; 188(1):91-7. PubMed ID: 22578729
    [Abstract] [Full Text] [Related]

  • 15. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer.
    Valicenti RK, Chervoneva I, Gomella LG.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1093-7. PubMed ID: 15001249
    [Abstract] [Full Text] [Related]

  • 16. Risk factors of positive surgical margin and biochemical recurrence of patients treated with radical prostatectomy: a single-center 10-year report.
    Li K, Li H, Yang Y, Ian LH, Pun WH, Ho SF.
    Chin Med J (Engl); 2011 Apr 15; 124(7):1001-5. PubMed ID: 21542957
    [Abstract] [Full Text] [Related]

  • 17. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):714-24. PubMed ID: 15708249
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer.
    Vis AN, Schröder FH, van der Kwast TH.
    Eur Urol; 2006 Aug 01; 50(2):258-65. PubMed ID: 16413660
    [Abstract] [Full Text] [Related]

  • 20. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
    Freedland SJ, Wieder JA, Jack GS, Dorey F, deKernion JB, Aronson WJ.
    J Urol; 2002 Jul 01; 168(1):110-5. PubMed ID: 12050502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.